For research use only
| Cat No. | ABC-X0061C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocyte |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The human AKT1 (D323H_C296S) BAF3 cell line provides a robust platform for studying tumor transformation and the efficacy of targeted inhibitors.
Human AKT1 (D323H_C296S) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. This model expresses the human AKT1 gene carrying dual point mutations D323H and C296S, integrated into Ba/F3 cells via lentiviral transduction.
Target
AKT1 is a serine/threonine kinase pivotal in mediating cell proliferation, metabolism, and survival through the PI3K/AKT/mTOR axis. Mutations D323H and C296S both reside in the kinase domain and are associated with altered activity, potentially leading to resistance against AKT-targeted therapies. AcceGen supports the development of customized dual-mutant models to enable detailed functional and pharmacological investigations. Polyclonal or monoclonal is optional.
| Species | Human |
| Cat.No | ABC-X0061C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocyte |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The AKT1 (D323H_C296S) BAF3 Cell Line provides a robust platform to study oncogenic transformation, mutation-specific signaling dynamics, and the efficacy of targeted inhibitors. It is ideal for therapeutic resistance screening and precision oncology research.